Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
International Journal of Cancer|October 13, 2025
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathwayMichiel Vlaming, Eveline M A Bleiker, Gina Schijven, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized TrialClaudia S E W Schuurhuizen, Annemarie M J Braamse, Aartjan T F Beekman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)Pieternella Johanna Lugtenburg, Peter de Nully Brown, Bronno van der Holt, et al.
Haematologica|April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL studyMarie José Kersten, Martin Dreyling, Kim M Linton, et al.
Blood Advances|April 18, 2025
Atezolizumab Consolidation in Patients with High Risk Diffuse Large B-cell Lymphoma in Complete Remission after R-CHOPMarcel Nijland, Djamila E Issa, Johanna A A Bult, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.
European Urology Open Science|April 21, 2025
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary ViewDaniela E Oprea-Lager, Tessa van Elst, Shafak Aluwini, et al.
Pageof 5